In the critical moments following a catastrophic injury, the difference between life and death is often measured not in minutes, but in milliliters of blood lost before a patient ever reaches the emergency room. For decades, first responders have navigated this uncertainty with limited tools,
Today, we sit down with Ivan Kairatov, a biopharma expert whose career has been dedicated to the intersection of technology, research, and development. As artificial intelligence begins to unlock the very code of life, it presents a dual-use dilemma of unprecedented scale—promising revolutionary
The immense complexity of the human brain, mirrored in the subtle and highly variable details of magnetic resonance images, has long presented a formidable challenge for both clinicians and researchers striving for earlier and more accurate diagnoses of neurological conditions. A groundbreaking AI
The well-trodden path for ambitious tech companies seeking capital and public validation has long been the traditional initial public offering, but a new class of innovators is now charting a course that fuses the rigor of Wall Street with the disruptive potential of Web3. Mexico City-based
Today we're joined by Ivan Kairatov, a biopharma expert with extensive experience in research and development. We'll be exploring the outcomes of a groundbreaking clinical trial that has identified a surprising new use for an old drug, offering significant relief to men undergoing hormone therapy
A promise of universal health care, once the gleaming centerpiece of Governor Gavin Newsom's progressive agenda for California, now appears tarnished by the harsh glare of fiscal austerity and national political ambition. The governor's controversial proposal to withhold state funding for health
